MedPath

哈尔滨圣泰生物制药有限公司

Ownership
-
Established
2011-08-29
Employees
-
Market Cap
-
Website
http://www.shengtaizhiyao.com

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

76

NMPA:76

Drug Approvals

Sodium Aescinate

Product Name
七叶皂苷钠
Approval Number
国药准字H20066883
Approval Date
Feb 5, 2025
NMPA

复方鱼腥草片

Approval Number
国药准字Z20093341
Approval Date
Mar 1, 2024
NMPA

小儿清肺止咳片

Approval Number
国药准字Z20093151
Approval Date
Mar 1, 2024
NMPA

Compound Bismuth Aluminate Tablets

Product Name
复方铝酸铋片
Approval Number
国药准字H20074203
Approval Date
Feb 26, 2024
NMPA

降糖宁胶囊

Approval Number
国药准字Z20093379
Approval Date
Feb 26, 2024
NMPA

消栓通络片

Approval Number
国药准字Z20083218
Approval Date
Aug 30, 2023
NMPA

灯盏花素片

Approval Number
国药准字Z20083169
Approval Date
Aug 28, 2023
NMPA

Azithromycin for Injection

Product Name
注射用阿奇霉素
Approval Number
国药准字H20073678
Approval Date
Aug 21, 2023
NMPA

Muscular Amino Acids and Peptides and Nucleosides for Injection

Product Name
维欣开
Approval Number
国药准字H20051451
Approval Date
Mar 31, 2023
NMPA

Diltiazem Hydrochloride for Injection

Product Name
健尔信
Approval Number
国药准字H20043054
Approval Date
Mar 31, 2023
NMPA
  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 8
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.